Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2864
Revised: April 22, 2004
Accepted: April 29, 2004
Published online: October 1, 2004
AIM: To evaluate the clinical value of plasma apolipoprotein A-I (Apo A-I) as a marker of fibrosis in children with chronic hepatitis B (CHB).
METHODS: Liver biopsy specimens from 49 children with CHB were evaluated by using Knodell index. Plasma Apo A-I level was measured after 12-h fasting. Student’s t test, Spearman’s correlation test and receptor-operating characteristic (ROC) curve were used for statistical evaluation.
RESULTS: Mean Apo A-I level of the patients was not different from that of controls (P > 0.05). Six (8.7%) children had fibrosis score of more than 2 (severe fibrosis). No difference in the level of mean plasma Apo A-I was found among children with and without severe fibrosis (P > 0.05). No correlation between Apo A-I level and fibrosis scores was found (P > 0.05). The area under the ROC curve was 0.407 ± 0.146 (P > 0.05).
CONCLUSION: Severe fibrosis is not common in children with CHB and plasma Apo A-I level is not a reliable indicator of fibrosis.